Annual Report

Overview

The report highlights BioArctic's 2019 clinical progress, with BAN2401 entering a global confirmatory Phase 3 study and ABBV-0805 beginning Phase 1. It reports consolidated total revenue of MSEK 296.6 and notes that the company generated an operating profit for the seventh consecutive year. Sustainability initiatives are organized around sustainable business, sustainable employeeship and sustainable resources.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: Ends 31 December 2019
Publication date: 31 March 2020
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services